In a report released today, Gavin Parsons from Goldman Sachs maintained a Buy rating on Leidos Holdings (LDOS – Research Report), with a price target of $118.00. The company’s shares closed last Monday at $101.84.
Parsons has an average return of 4.0% when recommending Leidos Holdings.
According to TipRanks.com, Parsons is ranked #4300 out of 7793 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Leidos Holdings with a $105.43 average price target, an 8.2% upside from current levels. In a report issued on February 17, Jefferies also maintained a Buy rating on the stock with a $110.00 price target.
Leidos Holdings’ market cap is currently $14.31B and has a P/E ratio of 19.35.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company’s customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.
Read More on LDOS:
- Workday (WDAY) Received its Third Buy in a Row
- Maxim Group Reiterates Their Buy Rating on Northwest Gas (NWN)
- Colliers Securities Reiterates a Buy Rating on Lincoln Edu (LINC)
- Colliers Securities Thinks Gaia’s Stock is Going to Recover
- Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT) and Atea Pharmaceuticals (AVIR)